Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Antimicrobial resistance and the threat of 'superbugs' recently hit the headlines. Researchers from DEC Oxford contributed to the paper which you can read in full below.

Blue petri-dish
Blue petri-dish

Lord Jim O’Neill’s global Review on AMR sets out its final recommendations, providing a comprehensive action plan for the world to prevent drug-resistant infections and defeat the rising threat of superbugs – something that could kill 10 million people a year by 2050, the equivalent of 1 person every 3 seconds, and more than cancer kills today. Building on eight interim papers, this is the final report from Lord O’Neill’s Review, established by the UK Prime Minister David Cameron in 2014 to avoid the world being “cast back into the dark ages of medicine”.

To read the paper, click here:

http://amr-review.org/

Similar stories

Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.

Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.

COVID-19: Online Medical Device Regulation Tool Goes Live

A digital tool to make it easier to understand how medical device regulations apply to your product in the current climate.

The NIHR's Response to COVID-19

The NIHR has established a single, national prioritisation process for COVID-19 research to prevent duplication of effort and ensure that the resources and capacity of the healthcare system are not exceeded.

£1.24 million for new medical diagnostics hub

University of Oxford researchers have been awarded £1.24 million to lead a medical diagnostics co-operative that will drive forward the development, evaluation and uptake of new medical diagnostic technologies to improve outcomes for patients in the community.

DEC's first Health Technology for Tomorrow seminar

On Friday 25th November, the Diagnostic Evidence Co-operative launched the first of a series of seminars to explore wearable technologies, imaging devices and digital health related technologies.